These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38646595)

  • 1. Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury
    Varache M; Rizzo S; Sayers EJ; Newbury L; Mason A; Liao CT; Chiron E; Bourdiec N; Jones A; Fraser DJ; Taylor PR; Jones AT; Thomas DW; Ferguson EL
    RSC Pharm; 2024 Apr; 1(1):68-79. PubMed ID: 38646595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the Antibiotic, Colistin, with Dextrin Causes Enhanced Cytotoxicity and Triggers Apoptosis in Myeloid Leukemia.
    Rizzo S; Varache M; Sayers EJ; Jones AT; Tonks A; Thomas DW; Ferguson EL
    Int J Nanomedicine; 2024; 19():5419-5437. PubMed ID: 38868592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer Masked-Unmasked Protein Therapy: Identification of the Active Species after Amylase Activation of Dextrin-Colistin Conjugates.
    Varache M; Powell LC; Aarstad OA; Williams TL; Wenzel MN; Thomas DW; Ferguson EL
    Mol Pharm; 2019 Jul; 16(7):3199-3207. PubMed ID: 31125239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dextrin-colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections.
    Ferguson EL; Azzopardi E; Roberts JL; Walsh TR; Thomas DW
    Mol Pharm; 2014 Dec; 11(12):4437-47. PubMed ID: 25360900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Evaluation of the Interaction of Dextrin-Colistin Conjugates with Bacterial Lipopolysaccharide.
    Roberts JL; Cattoz B; Schweins R; Beck K; Thomas DW; Griffiths PC; Ferguson EL
    J Med Chem; 2016 Jan; 59(2):647-54. PubMed ID: 26730548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.
    Miano TA; Lautenbach E; Wilson FP; Guo W; Borovskiy Y; Hennessy S
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):542-550. PubMed ID: 29545383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an in vitro pharmacokinetic/pharmacodynamic model to test the antibacterial efficacy of antibiotic polymer conjugates.
    Azzopardi EA; Ferguson EL; Thomas DW
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1837-43. PubMed ID: 25512401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapy.
    Ferguson EL; Richardson SC; Duncan R
    Mol Pharm; 2010 Apr; 7(2):510-21. PubMed ID: 20163158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A physicochemical assessment of the thermal stability of dextrin-colistin conjugates.
    Chiron E; Varache M; Stokniene J; Thomas DW; Ferguson EL
    Sci Rep; 2021 May; 11(1):10600. PubMed ID: 34011987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymer masked-unmasked protein therapy. 1. Bioresponsive dextrin-trypsin and -melanocyte stimulating hormone conjugates designed for alpha-amylase activation.
    Duncan R; Gilbert HR; Carbajo RJ; Vicent MJ
    Biomacromolecules; 2008 Apr; 9(4):1146-54. PubMed ID: 18348531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin nanoparticle assembly by coacervate complexation with polyanionic peptides for treating drug-resistant gram-negative bacteria.
    Liu YH; Kuo SC; Yao BY; Fang ZS; Lee YT; Chang YC; Chen TL; Hu CJ
    Acta Biomater; 2018 Dec; 82():133-142. PubMed ID: 30316023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review on colistin nephrotoxicity.
    Ordooei Javan A; Shokouhi S; Sahraei Z
    Eur J Clin Pharmacol; 2015 Jul; 71(7):801-10. PubMed ID: 26008213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephroprotective potential of Panduratin A against colistin-induced renal injury via attenuating mitochondrial dysfunction and cell apoptosis.
    Worakajit N; Thipboonchoo N; Chaturongakul S; Jutabha P; Soontornniyomkij V; Tuchinda P; Soodvilai S
    Biomed Pharmacother; 2022 Apr; 148():112732. PubMed ID: 35217281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β-mediated NADPH oxidase 4-dependent oxidative stress promotes colistin-induced acute kidney injury.
    Jeong BY; Park SR; Cho S; Yu SL; Lee HY; Park CG; Kang J; Jung DY; Park MH; Hwang WM; Yun SR; Jung JY; Yoon SH
    J Antimicrob Chemother; 2018 Apr; 73(4):962-972. PubMed ID: 29329393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
    Hardwicke J; Ferguson EL; Moseley R; Stephens P; Thomas DW; Duncan R
    J Control Release; 2008 Sep; 130(3):275-83. PubMed ID: 18700156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate.
    Ferguson EL; Duncan R
    Biomacromolecules; 2009 Jun; 10(6):1358-64. PubMed ID: 19354276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Activity and Toxicity of the Major Lipopeptide Components of Polymyxin B and Colistin: Last-line Antibiotics against Multidrug-Resistant Gram-negative Bacteria.
    Roberts KD; Azad MA; Wang J; Horne AS; Thompson PE; Nation RL; Velkov T; Li J
    ACS Infect Dis; 2015 Nov; 1(11):568-575. PubMed ID: 27525307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary neutrophil gelatinase-associated lipocalin for early detection of acute kidney injury in geriatric patients with urinary tract infection treated by colistin.
    Shavit L; Manilov R; Wiener-Well Y; Algur N; Slotki I
    Clin Nephrol; 2013 Dec; 80(6):405-16. PubMed ID: 24120670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin Nephrotoxicity-Age and Baseline kidney Functions Hold the Key.
    Prasannan BK; Mukthar FC; Unni VN; Mohan S; Vinodkumar K
    Indian J Nephrol; 2021; 31(5):449-453. PubMed ID: 34880554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin-Induced Acute Kidney Injury and the Effect on Survival in Patients with Multidrug-Resistant Gram-Negative Infections: Significance of Drug Doses Adjusted to Ideal Body Weight.
    Arrayasillapatorn N; Promsen P; Kritmetapak K; Anunnatsiri S; Chotmongkol W; Anutrakulchai S
    Int J Nephrol; 2021; 2021():7795096. PubMed ID: 34966562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.